Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE

• Main Authors: Mileka Gilbert (Author), Beatrice Goilav (Author), Joyce J. Hsu (Author), Paul J. Nietert (Author), Esra Meidan (Author), Annabelle Chua (Author), Stacy P. Ardoin (Author), Scott E. Wenderfer (Author), Emily von Scheven (Author), Natasha M. Ruth (Author), for the Pediatric Nephrology and Rheumatology Collaborative Group, the Childhood Arthritis and Rheumatology Research Alliance, and the American Society for Pediatric Nephrology (Author)
• Format: Book
• Published: BMC, 2021-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Consensus treatment plans have been developed for induction therapy of newly diagnosed proliferative lupus nephritis (LN) in childhood-onset systemic lupus erythematosus. However, patients who do not respond to initial therapy, or who develop renal flare after remission, warrant...